Lifecore Biomedical, Inc.

NasdaqGS LFCR

Lifecore Biomedical, Inc. Market Capitalization on January 14, 2025: USD 238.07 M

Lifecore Biomedical, Inc. Market Capitalization is USD 238.07 M on January 14, 2025, a -2.62% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Lifecore Biomedical, Inc. 52-week high Market Capitalization is USD 309.21 M on February 09, 2024, which is 29.88% above the current Market Capitalization.
  • Lifecore Biomedical, Inc. 52-week low Market Capitalization is USD 139.25 M on August 29, 2024, which is -41.51% below the current Market Capitalization.
  • Lifecore Biomedical, Inc. average Market Capitalization for the last 52 weeks is USD 223.76 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGS: LFCR

Lifecore Biomedical, Inc.

CEO Mr. Paul Josephs
IPO Date Feb. 15, 1996
Location United States
Headquarters 3515 Lyman Boulevard
Employees 524
Sector Health Care
Industries
Description

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

Similar companies

AKAN

Akanda Corp.

USD 1.53

-6.13%

IRWD

Ironwood Pharmaceuticals, Inc.

USD 3.65

-3.18%

DERM

Journey Medical Corporation

USD 3.73

-1.32%

CPIX

Cumberland Pharmaceuticals Inc.

USD 2.67

14.59%

StockViz Staff

January 15, 2025

Any question? Send us an email